Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07092501 · ClinicalTrials.gov registry record · NA
An Experimental Evaluation of Menthol-Flavored Tobacco Accessories
A NA study of Smoking Behaviors and Cigarette Smoking Behavior, sponsored by Virginia Polytechnic Institute and State University.
- Active
- Registry status
- NA
- Development phase
- 23
- Enrollment target
- 1
- Study location
NCT07092501: Active NA study of Smoking Behaviors and Cigarette Smoking Behavior, sponsored by Virginia Polytechnic Institute and State University.
NCT07092501 is a NA study of Smoking Behaviors and Cigarette Smoking Behavior that is active but no longer recruiting, run by Virginia Polytechnic Institute and State University. The registered enrollment target is 23 participants, below the 438-participant average among 21 other Smoking Behaviors trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07092501, a NA study of Smoking Behaviors and Cigarette Smoking Behavior, is active but no longer recruiting, sponsored by Virginia Polytechnic Institute and State University.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 23 participants
- Enrollment target
- 1
- Study location
Study Summary
In a within-subjects design in-laboratory study, participants will sample non-menthol cigarettes mentholated with various accessories (e.g., crush balls, filter tips, aroma cards) in a controlled setting. They will compare these to their preferred menthol brand using subjective ratings (e.g., liking, strength, ease of use) and complete purchase tasks and ETM trials to assess product demand and likelihood of future use.
Primary Outcome
Participants will provide the subjective ratings (e.g. liking, strength, ease of use) of each product in comparison to their usual menthol cigarette brand. The scale ranges from not at all (1) to extremely (7). Four factor scoring comprising stimulant effects (sum of items 5, 7 and 8, range from 3 to 21), positive reinforcement (sum of items 2, 3 and 12, range from 3 to 21), negative reinforcement (sum of items 4, 6 and 11, range from 3 to 21) and aversion (sum of items 9 and 10, range from 2 to
Conditions Studied
Interventions
- BEHAVIORAL Mentholated cigarette sampling
- BEHAVIORAL Hypothetical Policy Scenarios
- BEHAVIORAL Subjective value assessment
Study Locations (1)
Virginia
- Fralin Biomedical Research Institute at VTC - Roanoke
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 23 participants |
| Start Date | 2025-09-01 |
| Est. Completion | 2026-04-30 |
| Phase | NA |
What the registry record for NCT07092501 still lists
NCT07092501 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 23 participants, a relatively small participant target, below the 438-participant average among 21 other Smoking Behaviors trials with a reported enrollment target (95% lower).
The record links to 3 conditions, with Smoking Behaviors appearing as the primary indexed condition, and to 3 interventions - of which Mentholated cigarette sampling is the first listed.
NCT07092501 reports a single indexed study location in Virginia.
Frequently Asked Questions
What is clinical trial NCT07092501 about?
NCT07092501 is a clinical study titled "An Experimental Evaluation of Menthol-Flavored Tobacco Accessories". In a within-subjects design in-laboratory study, participants will sample non-menthol cigarettes mentholated with various accessories (e.g., crush balls, filter tips, aroma cards) in a controlled setting. They will compare these to their preferred menthol brand using subjective ratings (e.g., liking...
What is the current status of trial NCT07092501?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 23 participants. The study started on 2025-09-01. Estimated completion is 2026-04-30.
What conditions does trial NCT07092501 study?
This clinical trial studies the following conditions: Smoking Behaviors, Cigarette Smoking Behavior, Cigarette.
What interventions are being tested in trial NCT07092501?
The interventions under investigation include: Mentholated cigarette sampling (BEHAVIORAL), Hypothetical Policy Scenarios (BEHAVIORAL), Subjective value assessment (BEHAVIORAL).
Who is sponsoring clinical trial NCT07092501?
This trial is sponsored by Virginia Polytechnic Institute and State University, which has 104 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07092501 being conducted?
This trial has 1 study location across Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Smoking Behaviors
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07092501's enrollment target sits among peer trials
23 20th of 21 higher than 2 of 21 other Smoking Behaviors trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Smoking Behaviors trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Influence of Authorized Smokeless Tobacco Product Modified Risk Claims I: Consumer Product Demand
RECRUITING · NA
-
ACT Lung Health Intervention: Phase Two
RECRUITING · NA
-
Smoke Free SafeCare: Establishing a Smoke Free Home in CPS-involved Families
RECRUITING · NA
-
Take A Break - Rural
RECRUITING · NA
-
Effects of E-cigs vs Pouches on Cigarette Smoking and Addiction
RECRUITING · NA
-
A Clinical Trial of Adaptive Treatment for Early Smoking Cessation Relapse
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03616041 · 23 participants
Capsule Endoscopy for Severe Hematochezia
- NCT04348747 · 23 participants · Phase 2
Dendritic Cell Vaccines Against Her2/Her3 and Pembrolizumab for the Treatment of Brain Metastasis From Triple Negative Breast Cancer or HER2+ Breast Cancer
- NCT04587687 · 23 participants · Phase 2
Brentuximab Vedotin and Bendamustine for the Treatment of Relapsed or Refractory Follicular Lymphoma
- NCT04715022 · 23 participants · Phase 1
Sympathetic-vascular Dysfunction in Obesity and Insulin Resistance (Vitamin C Study)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI